Healthcare-focused private equity firm Linden Capital Partners completed the acquisition of independent clinical research site business Evolution Research Group LLC.
The deal, financial terms of which were not disclosed, builds on Linden's pharmaceutical services sub-sector strategy.
Watchung, N.J.-based Evolution Research, which provides medical and scientific clinical research site services in the neurosciences area, has completed over 5,000 clinical trials in phases 1 to 4.
Senior debt financing for the deal was provided by Golub Capital.
Kirkland & Ellis LLP served as legal adviser to Chicago-based Linden. Harris Williams & Co., Edgemont Capital Partners, and Ice Miller LLP served as financial and legal advisers to Evolution Research.
